Active · per the CBE, 31 October 2026

CureVac Belgium

BE0781532859

Rechtspersoon Public limited company 1 establishment

CureVac Belgium is a commercial agency in Ottignies-Louvain-la-Neuve. Public Limited, started on 3 February 2022, 1 establishment.

Courbevoie 13, 1348 Ottignies-Louvain-la-Neuve

Active for

4 year, 8 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Busy address KBO

    55 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

CureVac Belgium from Ottignies-Louvain-la-Neuve, company number BE0781532859, closed financial year 2025 with a result of € 30,278 after tax. For that financial year CureVac Belgium recorded a gross margin of € 5 million and equity of € 340,719. Compared with financial year 2024, the result moved from € 103,209 to € 30,278. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 1, 2026.

What it is worth Growing

€ 340,719

▲ 10% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 30,278

▼ 71% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 745,538

▲ 67% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 279,219.

People and assets in 2025

Full-time equivalents

10.2

▼ 2.9 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 4.8 million

▲ 9% vs 2024

€ 467,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 65,037

▲ 39% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 2.2 million

▲ 89% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Revenue € 1,112,266 - - -
Gross margin - € 3,107,634 € 4,592,797 € 4,985,502 ▲ 9%
Profit after taxes € -6,859 € 117,896 € 103,209 € 30,278 ▼ 71%
Equity € 54,641 € 207,231 € 310,441 € 340,719 ▲ 10%
Total debts € 1,393,024 € 2,706,052 € 3,465,218 € 3,287,484 ▼ 5%
Cash € 190,325 € 311,063 € 446,990 € 745,538 ▲ 67%
Retained profit € -6,859 € 145,731 € 248,941 € 279,219 ▲ 12%
Bank debt € 500,000 € 1,000,000 € 1,500,000 € 0 ▼ 100%
Balance sheet total € 1,447,665 € 2,913,284 € 3,775,659 € 3,628,203 ▼ 4%
Employees (FTE) 6.9 11.9 13.1 10.2 ▼ 2.9

Key figures of CureVac Belgium, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CureVac Belgium?

What happened at CureVac Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Arlène DERBAIX stepped down as director. NBB
  • Marco RAU stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 30,278 (▼ 71% vs 2024). filed late Source: NBB ↗
  • Vincent MOLINE stepped down as director. NBB
  • Vincent MOLINE became a director. NBB
  • Arlène DERBAIX became a director. NBB
  • New establishment in Ottignies-Louvain-la-Neuve. KBO
  • Start of the company according to the CBE. KBO

In short

From € 6,859 loss in 2022 to € 30,278 profit in 2025.

Paid € 328,756 in corporate taxes since 2022.

Best year ever: 2023, with € 117,896 profit.

On average € 488,800 of value added per employee in 2025.

Management

CureVac Belgium

The shares are held by BioNTech SE (100%).

Directors

According to the 2025 annual accounts

Vincent MOLINE

Director

since 2024 · until 2025

Marco RAU

Director

since 2022 · until 2029

Arlène DERBAIX

Director

since 2024 · until 2030

Shareholders

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Courbevoie 13

1348 Ottignies-Louvain-la-Neuve

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0781.532.859
VAT number
BE 0781.532.859
Registered office
Courbevoie 13, 1348 Ottignies-Louvain-la-Neuve
Names & denominations
CureVac Belgium
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
3 February 2022
Peppol
Active · Active since 27 Nov 2025
Activities · NACE

Handelsbemiddeling in de groothandel in andere specifieke goederen

Speur- en ontwikkelingswerk op biotechnologisch gebied

Frequently asked questions

What does CureVac Belgium do?
CureVac Belgium is a commercial agency in Ottignies-Louvain-la-Neuve. Public Limited, started on 3 February 2022, 1 establishment.
What is the address of CureVac Belgium?
The registered office of CureVac Belgium is located at Courbevoie 13, 1348 Ottignies-Louvain-la-Neuve.
Is CureVac Belgium still active?
Yes. According to the CBE (31 October 2026) CureVac Belgium is active, legal situation “Normale toestand”, started on 3 February 2022.
Is CureVac Belgium registered on Peppol?
Yes, CureVac Belgium is registered on the Peppol network with ID 0208:0781532859.
What is the enterprise number of CureVac Belgium?
The enterprise number of CureVac Belgium is BE0781532859.
When was CureVac Belgium founded?
CureVac Belgium was founded on 3 February 2022.